Legal & General Group PLC Arvinas, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 53,610 shares of ARVN stock, worth $981,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,610

Previous 62,954 14.84%

Holding current value

$981,599

Previous $1.55 Million 33.74%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$17.83 - $28.04 $166,603 - $262,005	-9,344 Reduced 14.84%	53,610 $1.03 Million
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $46,066 - $63,725	-1,947 Reduced 3.0%	62,954 $1.55 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $176,429 - $291,405	7,213 Added 12.5%	64,901 $1.73 Million
Q1 2024 May 14, 2024	BUY	$36.38 - $52.31 $398,797 - $573,422	10,962 Added 23.46%	57,688 $2.38 Million
Q4 2023 Feb 15, 2024	SELL	$14.19 - $42.33 $3,135 - $9,354	-221 Reduced 0.47%	46,726 $1.92 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $19,679 - $28,266	1,002 Added 2.18%	46,947 $922,000
Q2 2023 Aug 14, 2023	SELL	$21.73 - $31.43 $16,927 - $24,483	-779 Reduced 1.67%	45,945 $1.14 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $144,112 - $205,339	5,511 Added 13.37%	46,724 $1.28 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $15,585 - $27,475	-480 Reduced 1.15%	41,213 $1.41 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $70,844 - $98,119	1,692 Added 4.23%	41,693 $1.86 Million
Q2 2022 Aug 22, 2022	BUY	$36.01 - $74.24 $77,133 - $159,022	2,142 Added 5.66%	40,001 $1.68 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $54,122 - $73,249	898 Added 2.43%	37,859 $2.55 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $173,119 - $252,936	2,629 Added 7.66%	36,961 $3.04 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $532,749 - $785,077	7,278 Added 26.9%	34,332 $2.82 Million
Q2 2021 Aug 12, 2021	BUY	$60.45 - $84.26 $260,660 - $363,329	4,312 Added 18.96%	27,054 $2.08 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $1.01 Million - $1.59 Million	17,413 Added 326.76%	22,742 $1.5 Million
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $107,592 - $452,591	5,329 New	5,329 $453,000

Others Institutions Holding ARVN

# of Institutions

223

Shares Held

70.9M

Call Options Held

1.52M

Put Options Held

346K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $974M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Arvinas, Inc. Transaction History